Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

Review

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

       
Total article views   HTML views PDF downloads Totals
8,360 Dovepress* 6,144+ 1,394 7,538
PubMed Central* 2,216 480 2,696
Totals 8,360 1,874 10,234
*Since 3 December 2019

View citations on PubMed Central and Google Scholar